Johnson Johnson Launches Campaign to Address Depression Treatment Gaps
Johnson & Johnson has launched the 'Generation Fine' campaign to address the pessimism among patients with major depressive disorder (MDD) regarding their treatment outcomes. A survey revealed that many patients feel their symptoms are not fully addressed by current antidepressants. The campaign, in partnership with Mental Health America, aims to empower patients to discuss their symptoms with healthcare providers and challenge the notion of feeling 'fine' as an acceptable outcome. The initiative is supported by mental health advocates, including former NFL player Kyle Long. 
